Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The type of diabetes is identified by the dysfunction causing the hyperglycemia
TRIUMPH-4 (Phase 3, 68 weeks) 12mg dose: 28.7% weight loss (~71 lbs / 32 kg average) 9mg dose: 26.4% weight loss (~64 lbs / 29 kg average) Patients also saw 76% reduction in knee osteoarthritis pain Blood pressure reduced by 14 mmHg on average Source: ClinicalTrials.gov (TRIUMPH-4, NCT05931367) The TRIUMPH Phase 3 program includes 4 trials studying retatrutide for obesity, type 2 diabetes, and cardiovascular outcomes
Lay down immediately after administration to maximize absorption
One more thing in my preserving everything GLP-1 stack: my Lumebox red light therapy device
US$ 22.32
US$ 29.18
US$ 22.64
US$ 27.02
US$ 28.51
US$ 27.64
